A House hearing on the Food and Drug Administration’s oversight of the use of hemp ingredients in food and dietary supplements gave Republican members a stage to broadly criticize the FDA while their Democrat counterparts offered support for the agency’s request for additional authorities.
Meanwhile, members from both parties and both chambers announced a request for information from subject matter experts and stakeholders regarding the FDA’s regulation of hemp. The chairs and ranking members of the House Energy and Commerce Committee and Senate Health, Education, Labor and Pensions Committee say they “are assessing the potential for a regulatory pathway for hemp-derived [cannabidiol] products that prioritizes consumer safety and provides certainty to the U.S
The Oversight and Accountability Committee’s Health Care and Financial Services Subcommittee hearing on 27 July, “Hemp in the Modern World: The Yearslong Wait for FDA Action,” was for